amantadine has been researched along with Cognitive Decline in 3 studies
amant: an antiviral compound consisting of an adamantane derivative chemically linked to a water-solube polyanioic matrix; structure in first source
| Excerpt | Relevance | Reference |
|---|---|---|
| "Sepsis induces neuroinflammation and cognitive impairment, which were attenuated by amantadine." | 7.88 | Amantadine attenuates sepsis-induced cognitive dysfunction possibly not through inhibiting toll-like receptor 2. ( Huang, P; Lu, Y; Xing, W; Zeng, W; Zuo, Z, 2018) |
| "Facing the outbreak of coronavirus disease 2019 (COVID-19) pandemic, there is an urgent need to find protective or curable drugs to prevent or to stop the course of the coronavirus SARS-CoV-2 infection." | 5.56 | Adamantanes might be protective from COVID-19 in patients with neurological diseases: multiple sclerosis, parkinsonism and cognitive impairment. ( Grieb, P; Rejdak, K, 2020) |
| "Amantadine was generally well-tolerated despite substantial dosage and duration of therapy." | 5.48 | Amantadine: A new treatment for refractory electrical status epilepticus in sleep. ( Eliyan, Y; Hussain, SA; Sankar, R; Wilson, RB, 2018) |
| "Sepsis induces neuroinflammation and cognitive impairment, which were attenuated by amantadine." | 3.88 | Amantadine attenuates sepsis-induced cognitive dysfunction possibly not through inhibiting toll-like receptor 2. ( Huang, P; Lu, Y; Xing, W; Zeng, W; Zuo, Z, 2018) |
| "Facing the outbreak of coronavirus disease 2019 (COVID-19) pandemic, there is an urgent need to find protective or curable drugs to prevent or to stop the course of the coronavirus SARS-CoV-2 infection." | 1.56 | Adamantanes might be protective from COVID-19 in patients with neurological diseases: multiple sclerosis, parkinsonism and cognitive impairment. ( Grieb, P; Rejdak, K, 2020) |
| "Amantadine was generally well-tolerated despite substantial dosage and duration of therapy." | 1.48 | Amantadine: A new treatment for refractory electrical status epilepticus in sleep. ( Eliyan, Y; Hussain, SA; Sankar, R; Wilson, RB, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Rejdak, K | 1 |
| Grieb, P | 1 |
| Xing, W | 1 |
| Huang, P | 1 |
| Lu, Y | 1 |
| Zeng, W | 1 |
| Zuo, Z | 1 |
| Wilson, RB | 1 |
| Eliyan, Y | 1 |
| Sankar, R | 1 |
| Hussain, SA | 1 |
3 other studies available for amantadine and Cognitive Decline
| Article | Year |
|---|---|
Adamantanes might be protective from COVID-19 in patients with neurological diseases: multiple sclerosis, parkinsonism and cognitive impairment.
Topics: Adamantane; Adult; Aged; Aged, 80 and over; Amantadine; Asymptomatic Infections; Betacoronavirus; Co | 2020 |
Amantadine attenuates sepsis-induced cognitive dysfunction possibly not through inhibiting toll-like receptor 2.
Topics: Amantadine; Animals; Behavior, Animal; Cognitive Dysfunction; Hippocampus; Male; Maze Learning; Mice | 2018 |
Amantadine: A new treatment for refractory electrical status epilepticus in sleep.
Topics: Adolescent; Amantadine; Autistic Disorder; Child; Child, Preschool; Cognition; Cognitive Dysfunction | 2018 |